EGFR and cancer: Combining these stains could potentially distinguish cells with sustained ERK activity (e.g., RAS mutants41) or cells with highly stochastic ERK activity (e.g., EGFR-driven cancer cells11,29) from cells in which ERK is activated in an organized pattern (e.g., non-tumor tissue44–46).